344 related articles for article (PubMed ID: 6709661)
1. Incidence of estrogen, progesterone and prolactin receptors in human breast cancer.
Calandra RS; Charreau EH; Royer de Giaroli M; Baldi A
Prog Clin Biol Res; 1984; 142():97-108. PubMed ID: 6709661
[TBL] [Abstract][Full Text] [Related]
2. Distribution, frequency, and quantitative analysis of estrogen, progesterone, androgen, and glucocorticoid receptors in human breast cancer.
Allegra JC; Lippman ME; Thompson EB; Simon R; Barlock A; Green L; Huff KK; Do HM; Aitken SC
Cancer Res; 1979 May; 39(5):1447-54. PubMed ID: 427788
[TBL] [Abstract][Full Text] [Related]
3. Lack of relationship between the levels of prolactin receptors and steroid receptors in women with breast cancer.
Ben-David M; Wittliff JL; Fekete M; Kadar T; Biran S; Schally AV
Biomed Pharmacother; 1988; 42(5):327-34. PubMed ID: 3191209
[TBL] [Abstract][Full Text] [Related]
4. Lactate dehydrogenase in breast carcinoma: correlation with estrogen and progesterone receptors.
Brentani MM; Nagai MA
Cancer Detect Prev; 1983; 6(1-2):241-7. PubMed ID: 6883383
[TBL] [Abstract][Full Text] [Related]
5. Comparison of an immunocytochemical assay for progesterone receptor with a biochemical method of measurement and immunocytochemical examination of the relationship between progesterone and estrogen receptors.
Berger U; Wilson P; Thethi S; McClelland RA; Greene GL; Coombes RC
Cancer Res; 1989 Sep; 49(18):5176-9. PubMed ID: 2766287
[TBL] [Abstract][Full Text] [Related]
6. Steroid receptors in breast cancer.
Desombre ER
Monogr Pathol; 1984; (25):149-74. PubMed ID: 6377047
[TBL] [Abstract][Full Text] [Related]
7. Comparison of triple-negative and estrogen receptor-positive/progesterone receptor-positive/HER2-negative breast carcinoma using quantitative fluorine-18 fluorodeoxyglucose/positron emission tomography imaging parameters: a potentially useful method for disease characterization.
Basu S; Chen W; Tchou J; Mavi A; Cermik T; Czerniecki B; Schnall M; Alavi A
Cancer; 2008 Mar; 112(5):995-1000. PubMed ID: 18098228
[TBL] [Abstract][Full Text] [Related]
8. Estrogen receptor status in breast cancer.
Wright CJ
Can J Surg; 1980 Jul; 23(4):316-7. PubMed ID: 7417890
[TBL] [Abstract][Full Text] [Related]
9. International comparisons concerning breast cancer and steroid receptors.
Matsumoto K; Sakamoto G; Nomura Y
Anticancer Res; 1986; 6(4):621-4. PubMed ID: 3752942
[TBL] [Abstract][Full Text] [Related]
10. [Demonstration of the effect of estrogen and progesterone receptors on survival in breast cancer without cytostatic and hormonal treatment in a small set of patients].
Hochmann J
Klin Onkol; 2010; 23(1):25-33. PubMed ID: 20192071
[TBL] [Abstract][Full Text] [Related]
11. Assessment of results of estrogen and progesterone receptor assays performed in a community hospital.
Szakacs JG; Arroyo JG; Girgenti AJ
Ann Clin Lab Sci; 1986; 16(4):266-73. PubMed ID: 3740795
[TBL] [Abstract][Full Text] [Related]
12. Steroid receptors in cystosarcoma phyllodes.
Brentani MM; Nagai MA; Oshima CT; Pacheco MM; Góes JC; Lemos LB
Cancer Detect Prev; 1982; 5(2):211-9. PubMed ID: 6290062
[TBL] [Abstract][Full Text] [Related]
13. Association of hormone replacement therapy to estrogen and progesterone receptor status in invasive breast carcinoma.
Chen WY; Hankinson SE; Schnitt SJ; Rosner BA; Holmes MD; Colditz GA
Cancer; 2004 Oct; 101(7):1490-500. PubMed ID: 15378477
[TBL] [Abstract][Full Text] [Related]
14. Biochemically estrogen receptor-negative, progesterone receptor-positive breast carcinoma. Immunocytochemical hormone receptors and prognostic factors.
Keshgegian AA
Arch Pathol Lab Med; 1994 Mar; 118(3):240-4. PubMed ID: 8135626
[TBL] [Abstract][Full Text] [Related]
15. Correlation of steroid receptors in synchronous tissues with survival in breast cancer patients.
Bhatavdekar JM; Patel DD; Karelia NH; Suthar TP; Shah NG; Vora HH; Ghosh N; Nadkarni SP; Balar DB
Neoplasma; 1993; 40(3):177-80. PubMed ID: 8350965
[TBL] [Abstract][Full Text] [Related]
16. Endogenous estrogen, androgen, and progesterone concentrations and breast cancer risk among postmenopausal women.
Missmer SA; Eliassen AH; Barbieri RL; Hankinson SE
J Natl Cancer Inst; 2004 Dec; 96(24):1856-65. PubMed ID: 15601642
[TBL] [Abstract][Full Text] [Related]
17. Hormone receptors and Japanese breast cancer.
Matsumoto K; Kitamura Y; Sugano H
Acta Pathol Jpn; 1982; 32 Suppl 1():145-54. PubMed ID: 6764994
[TBL] [Abstract][Full Text] [Related]
18. Body size, physical activity, and breast cancer hormone receptor status: results from two case-control studies.
Enger SM; Ross RK; Paganini-Hill A; Carpenter CL; Bernstein L
Cancer Epidemiol Biomarkers Prev; 2000 Jul; 9(7):681-7. PubMed ID: 10919738
[TBL] [Abstract][Full Text] [Related]
19. Clinical correlations of steroid receptors and male breast cancer.
Everson RB; Lippman ME; Thompson EB; McGuire WL; Wittliff JL; De Sombre ER; Jensen EV; Singhakowinta A; Brooks SC; Neifeld JP
Cancer Res; 1980 Apr; 40(4):991-7. PubMed ID: 7357565
[TBL] [Abstract][Full Text] [Related]
20. Absence of progesterone receptor associated with secondary breast cancer in postmenopausal women.
Balleine RL; Earl MJ; Greenberg ML; Clarke CL
Br J Cancer; 1999 Mar; 79(9-10):1564-71. PubMed ID: 10188907
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]